Key points are not available for this paper at this time.
sphingolipidoses, the mucopolysaccharidoes, the glycoproteinoses, mucolipi- doses, together with acid lipase deficiency diseases and glycogenosis type II.The penultimate chapter deals in a clear manner with the general approach to the treatment of lysosomal storage diseases, the final chapter being a 'Look to the Future'.Thoroughly recommended!
P R Dear (Sat,) studied this question.